VHA DIRECTIVE 1315 Transmittal Sheet December 8, 2017
RECERTIFICATION: This VHA directive is scheduled for recertification on or before the last working day of December 2022. This VHA directive will continue to serve as national VHA policy until it is recertified or rescinded.

Read More…

VA Says It Will Not Study Effects Of Medical Marijuana On PTSD And Chronic Pain

The Department of Veterans Affairs will not conduct research into the effects of medical cannabis on post-traumatic stress disorder and chronic pain — some of the very ailments veteran patients rely on the drug to treat.

In a Dec. 21 letter to Minnesota Democrat Rep. Tim Walz, VA Secretary David Shulkin said that the department is unable to research medical cannabis due to federal restrictions. “VA is committed to researching and developing effective ways to help Veterans cope with post-traumatic stress disorder and chronic pain conditions.

“However, federal law restricts VA’s ability to conduct research involving medical marijuana, or to refer veterans to such projects,” he added.

Read More Here….

U.S. Department of Veterans Affairs
What the VA has to say about Veterans and Cannabis

Read more here ….

Screen Shot 2015-01-31 at 7.29.37 PM Make the Connection:
“Locate Information and Resources
No matter what you may be experiencing, there is support for getting your life on a better track. Many, many Veterans have found the strength to reach out and make the connection. To find the Veteran resources most helpful for you, fill in your zip code or state below and then check the boxes to indicate the programs or topics you are interested in learning more about.”
Read More…


Screen Shot 2014-12-12 at 7.53.47 PMVeterans for Medical Cannabis Access
“Veterans for Medical Cannabis Access is committed to protecting the rights of veteran patients and health care professionals by advocating for safe and legal access to cannabis (marijuana) for all appropriate therapeutic uses and to encourage research on cannabis as a treatment alternative.”        Read More…


Contact us:
Email, Facebook